Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Frauke Adams
Metabolic Actions Could Confound Advantageous Effects of Combined Angiotensin II Receptor and Neprilysin Inhibition
Hypertension
Internal Medicine
Related publications
Will We Ever Use Angiotensin Receptor Neprilysin Inhibition (ARNi) for the Treatment of Hypertension?
Blood Pressure
Internal Medicine
Medicine
Cardiovascular Medicine
Cardiology
Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Angiotensin-Converting Enzyme Inhibition Potentiates Angiotensin II Type 1 Receptor Effects on Renal Bradykinin and cGMP
Hypertension
Internal Medicine
Neurogenic Actions of Angiotensin II.
Hypertension
Internal Medicine
NAD(P)H Oxidase Inhibition Attenuates Neuronal Chronotropic Actions of Angiotensin II
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Renoprotective Effects of an Angiotensin II Receptor Blocker in Experimental Model Rats With Hypertension and Metabolic Disorders
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Effects of Acute Angiotensin II Type 1 Receptor Antagonism and Angiotensin Converting Enzyme Inhibition on Plasma Fibrinolytic Parameters in Patients With Heart Failure
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Inhibition of Methamphetamine Self-Administration and Reinstatement by Central Blockade of Angiotensin II Receptor in Rats
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Angiotensin II Type 2 Receptor Gene Transfer Elicits Cardioprotective Effects in an Angiotensin II Infusion Rat Model of Hypertension
Physiological Genomics
Genetics
Physiology
